CHRONIC LYMPHOCYTIC LEUKEMIA REFRACTORY

Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA REFRACTORY trials appear

Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New 'Living Drug' trial offers hope for patients with aggressive blood cancers

Disease control Recruiting now

This early-stage trial is testing the safety and best dose of a new type of personalized cell therapy called MB-CART19.1. It is for adults and children (ages 2-70) with certain B-cell blood cancers that have come back or have not responded to standard treatments. Doctors will col…

Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA REFRACTORY

Phase: PHASE1 • Sponsor: Nelson Hamerschlak • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

CHRONIC LYMPHOCYTIC LEUKEMIA REFRACTORY

Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA REFRACTORY trials appear

New 'Living Drug' trial offers hope for patients with aggressive blood cancers